211 related articles for article (PubMed ID: 36793057)
61. Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes.
Bao L; Zhang Y; Zhang G; Jiang D; Yan D
Commun Biol; 2023 Feb; 6(1):226. PubMed ID: 36854740
[TBL] [Abstract][Full Text] [Related]
62. Additional
Panpetch W; Hiengrach P; Nilgate S; Tumwasorn S; Somboonna N; Wilantho A; Chatthanathon P; Prueksapanich P; Leelahavanichkul A
Gut Microbes; 2020 May; 11(3):465-480. PubMed ID: 31530137
[TBL] [Abstract][Full Text] [Related]
63. Chicken Intestinal Mycobiome: Initial Characterization and Its Response to Bacitracin Methylene Disalicylate.
Robinson K; Xiao Y; Johnson TJ; Chen B; Yang Q; Lyu W; Wang J; Fansler N; Becker S; Liu J; Yang H; Zhang G
Appl Environ Microbiol; 2020 Jun; 86(13):. PubMed ID: 32358003
[TBL] [Abstract][Full Text] [Related]
64. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder.
Hartmann P; Lang S; Zeng S; Duan Y; Zhang X; Wang Y; Bondareva M; Kruglov A; Fouts DE; Stärkel P; Schnabl B
Front Physiol; 2021; 12():699253. PubMed ID: 34349667
[TBL] [Abstract][Full Text] [Related]
65. Malian Children's Core Gut Mycobiome.
Abdillah A; Kodio A; Ranque S
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792756
[TBL] [Abstract][Full Text] [Related]
66. Characterization of the Intestinal Fungal Microbiome in HIV and HCV Mono-Infected or Co-Infected Patients.
Yin Y; Tuohutaerbieke M; Feng C; Li X; Zhang Y; Xu Q; Tu J; Yang E; Zou Q; Shen T
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016433
[TBL] [Abstract][Full Text] [Related]
67. Mucosal IgA Prevents Commensal
Millet N; Solis NV; Swidergall M
Front Immunol; 2020; 11():555363. PubMed ID: 33193324
[TBL] [Abstract][Full Text] [Related]
68. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
69. The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?
Musumeci S; Coen M; Leidi A; Schrenzel J
Clin Microbiol Infect; 2022 Jan; 28(1):58-63. PubMed ID: 34363944
[TBL] [Abstract][Full Text] [Related]
70.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
71. Alterations of gut fungal microbiota in patients with rheumatoid arthritis.
Sun X; Wang Y; Li X; Wang M; Dong J; Tang W; Lei Z; Guo Y; Li M; Li Y
PeerJ; 2022; 10():e13037. PubMed ID: 35251791
[TBL] [Abstract][Full Text] [Related]
72. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
73. Altered gut bacterial-fungal interkingdom networks in patients with current depressive episode.
Jiang HY; Pan LY; Zhang X; Zhang Z; Zhou YY; Ruan B
Brain Behav; 2020 Aug; 10(8):e01677. PubMed ID: 32533650
[TBL] [Abstract][Full Text] [Related]
74. Granulocyte-macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation.
Wu YN; Zhang L; Chen T; Li X; He LH; Liu GX
World J Gastroenterol; 2020 Sep; 26(36):5420-5436. PubMed ID: 33024394
[TBL] [Abstract][Full Text] [Related]
75. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC
Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057
[TBL] [Abstract][Full Text] [Related]
76. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
77. C-Type Lectin Receptors-Triggered Antifungal Immunity May Synergize with and Optimize the Effects of Immunotherapy in Hepatocellular Carcinoma.
Xia J; Ding H; Liu S; An R; Shi X; Chen M; Ren H
J Inflamm Res; 2023; 16():19-33. PubMed ID: 36636249
[TBL] [Abstract][Full Text] [Related]
78. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
[TBL] [Abstract][Full Text] [Related]
79. Early gut mycobiota and mother-offspring transfer.
Schei K; Avershina E; Øien T; Rudi K; Follestad T; Salamati S; Ødegård RA
Microbiome; 2017 Aug; 5(1):107. PubMed ID: 28837002
[TBL] [Abstract][Full Text] [Related]
80. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
